Application

LUROSIL

Pacific Health Collaborative, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90539634
Filing Date: 02/22/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90539634
MARK INFORMATION
*MARK Lurosil
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT Lurosil
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Pacific Health Collaborative, Inc.
*MAILING ADDRESS 1305 11th St., Ste. 202
*CITY Bellingham
*STATE
(Required for U.S. applicants)
Washington
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
98225
PHONE 360-594-4900
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Washington
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Vitamin/Mineral Dietary Supplement designed for joint health and natural control of inflammation.
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 02/01/2005
       FIRST USE IN COMMERCE DATE At least as early as 02/01/2005
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-15462875-20210216042 002152498_._Lurosil.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT18\IMAGEOUT 18\905\396\90539634\xml1\ APP0003.JPG
       SPECIMEN DESCRIPTION website page showing the mark used in commerce for product
        WEBPAGE URL http://www.lurosil.com/default.aspx
        WEBPAGE DATE OF ACCESS 02/16/2021
CORRESPONDENCE INFORMATION
NAME Pacific Health Collaborative, Inc.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE briang@pachealth.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /Brian Grote/
SIGNATORY'S NAME Brian Grote
SIGNATORY'S POSITION Agent
SIGNATORY'S PHONE NUMBER 360-594-4900
DATE SIGNED 02/16/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 90539634
Filing Date: 02/22/2021

To the Commissioner for Trademarks:

MARK: Lurosil (Standard Characters, see mark)
The literal element of the mark consists of Lurosil. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Pacific Health Collaborative, Inc., a corporation of Washington, having an address of
      1305 11th St., Ste. 202
      Bellingham, Washington 98225
      United States
      360-594-4900(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Vitamin/Mineral Dietary Supplement designed for joint health and natural control of inflammation.

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 02/01/2005, and first used in commerce at least as early as 02/01/2005, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) website page showing the mark used in commerce for product.

Original PDF file:
SPE0-15462875-20210216042 002152498_._Lurosil.pdf
Converted PDF file(s) (1 page)
Specimen File1
Webpage URL: http://www.lurosil.com/default.aspx
Webpage Date of Access: 02/16/2021


The applicant's current Correspondence Information:
      Pacific Health Collaborative, Inc.
       PRIMARY EMAIL FOR CORRESPONDENCE: briang@pachealth.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Brian Grote/   Date: 02/16/2021
Signatory's Name: Brian Grote
Signatory's Position: Agent
Signatory's Phone Number: 360-594-4900
Signature method: Sent to third party for signature
Payment Sale Number: 90539634
Payment Accounting Date: 02/22/2021

Serial Number: 90539634
Internet Transmission Date: Mon Feb 22 17:24:54 ET 2021
TEAS Stamp: USPTO/BAS-XXX.X.XX.XX-202102221724542795
92-90539634-7703f34cdf0f4ef86ee219e44f68
16dbb6ab8298abaf2a6ca4a387522eb23b5a7e2-
CC-24532911-20210216042002152498

Application [image/jpeg]

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed